| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |